Navigation Links
GenScript Announces Collaboration with AMDeC: Seeks to Decrease Biological Research Costs at NYC Area Institutions
Date:12/11/2012

PISCATAWAY, N.J., Dec. 11, 2012 /PRNewswire/ -- GenScript has cemented an alliance with AMDeC, LLC, becoming a member of AMDeC's Vendor Partnership Program. The program unites academic investigators with commercial entities by providing discounted vendor pricing to consortium members, which includes NYC area research institutions, like NYU Langone Medical Center and Weill Cornell Medical College.

GenScript is offering AMDeC members DNA sequencing services at deeply discounted prices. The services feature an easy, flexible sample submission and short turnaround times. But financial incentives aren't the only motivation for this collaboration. DNA sequencing has been a catalyst for biological research since the 1970s. Access to fast, affordable sequencing has enabled researchers to sequence the first human genome, and study a variety of gene functions. Hence, the value of sequencing services to the research community has increased, as service turnaround times and prices have decreased. The GenScript-AMDeC collaboration provides scientists with rapid, economical, high-quality sequencing services, which will help accelerate research in the NYC area.

That's just the tip of the iceberg for GenScript's CEO, Frank Zhang, Ph.D., who anticipates that through this collaboration, GenScript will eventually offer its complete arsenal of one-stop custom services, including gene and peptide synthesis, protein expression and purification, antibody production, and cell line development. Access to these premier services would have the same catalytic effect as DNA sequencing has had over the years, since outsourcing these tasks expedites academic laboratory research.

"By working with AMDeC, we hope to establish services [at] every single university in the USA," said Zhang. "Our vision is to make the research easy by providing custom reagents to scientists…[so that] the productivity in academic research labs will be improved."

Both GenScript and AMDeC are committed to accelerating discoveries in biological research. Thus, it's no coincidence that the potential for advancements in science and technology through this alliance is in parallel with AMDeC's assertion as "A Catalyst for Breakthroughs" and GenScript's core motto, "Transforming Biology Research".

*Read more about the GenScript-AMDeC collaboration in the November 2012 issue of Nature Medicine.

About GenScript

Founded in 2002, GenScript is a leading biology CRO offering customized services to aid biological research, and drug discovery/development. GenScript is headquartered in Piscataway, NJ, with subsidiaries in Europe, Japan, and China.


'/>"/>
SOURCE GenScript USA Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. GenScript to Synthesize Yeast Genome with Johns Hopkins Scientists
2. GenScript Honored with the 2012 CRO Leadership Award
3. GenScript Rush Gene Synthesis - Driving Molecular Biology Research Faster
4. Sequenom Announces Leadership Appointments
5. Rusty Cage Announces Rusterizer's 30% New Year Special Discount
6. IntelliCell BioSciences Announces the Addition of Harry Fisch, MD as Director of Urology
7. Verenium Announces $22.5 Million, Five-Year Secured Financing
8. Stemline Therapeutics, Inc. Announces Presentations of SL-401 Updated Clinical Trial Results in Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and SL-101 Preclinical Efficacy Data Against Hodgkins Lymphoma at
9. ISPE Announces 2012 Award Winners at Global Annual Meeting
10. Sequenom, Inc. Announces Issuance Of Patent For Methods Of Detecting Fetal Aneuploidy
11. Inovio Pharmaceuticals Announces Positive Interim Results in Phase II Leukemia Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 28, 2017 , ... Ecovia Renewables, Inc. announced today that ... from the National Science Foundation (NSF). Under the award , Ecovia Renewables, ... BioGel™ biopolymer materials for hygiene applications, particularly for use in the absorbent cores ...
(Date:3/28/2017)... , March 28, 2017 ... better understand Enzo Biochem and its partnering interests and activities ... 2010 report provides an in-depth insight into the partnering activity ... On demand company reports are prepared upon purchase to ... company data. The report will be delivered in ...
(Date:3/28/2017)... , Belgium , March 28, 2017 ... VolitionRx Limited (NYSE MKT: VNRX), today announced the engagement of ... DVD Associates, LLC, as a strategic consultant. Dr. Vollmer ... identifying and securing non-dilutive funding in the State ... United States . Dr. Vollmer Dahlke has ...
(Date:3/28/2017)... 28, 2017  Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), ... novel therapies for metabolic and endocrine disorders, today announced ... Ph.D., will deliver a corporate presentation at H.C. Wainwright ... being held April 3, 2017 at the St. Regis ... this presentation are as follows: ...
Breaking Biology Technology:
(Date:3/23/2017)... 23, 2017 Research and Markets has announced ... & Trends - Industry Forecast to 2025" report to their ... The ... CAGR of around 8.8% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/20/2017)... , March 20, 2017 At this year,s CeBIT ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together ... is this year,s CeBIT partner country. At the largest German biometrics company ... use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics system.   ... ...
(Date:3/9/2017)... March 9, 2017 4Dx has publicly released ... Imaging Workshop at the University of Pennsylvania. Founder and ... deliver the latest data to world leaders in lung ... together leaders at the forefront of the industry to ... "The quality of the imaging is ...
Breaking Biology News(10 mins):